JP2023528220A5 - - Google Patents
Info
- Publication number
- JP2023528220A5 JP2023528220A5 JP2022569147A JP2022569147A JP2023528220A5 JP 2023528220 A5 JP2023528220 A5 JP 2023528220A5 JP 2022569147 A JP2022569147 A JP 2022569147A JP 2022569147 A JP2022569147 A JP 2022569147A JP 2023528220 A5 JP2023528220 A5 JP 2023528220A5
- Authority
- JP
- Japan
- Prior art keywords
- mitochondrial
- composition according
- seq
- pharmaceutical composition
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063025495P | 2020-05-15 | 2020-05-15 | |
| US63/025,495 | 2020-05-15 | ||
| PCT/US2021/032641 WO2021231988A2 (en) | 2020-05-15 | 2021-05-14 | Mitochondrial-derived peptides and analogs thereof for use as a therapy for age-related diseases including cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023528220A JP2023528220A (ja) | 2023-07-04 |
| JP2023528220A5 true JP2023528220A5 (https=) | 2024-05-20 |
Family
ID=78525101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022569147A Pending JP2023528220A (ja) | 2020-05-15 | 2021-05-14 | がんを含む加齢関連疾患の治療法として使用するためのミトコンドリア由来ペプチドおよびそのアナログ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12577281B2 (https=) |
| EP (1) | EP4149511B1 (https=) |
| JP (1) | JP2023528220A (https=) |
| KR (1) | KR20230019112A (https=) |
| CN (1) | CN115697373A (https=) |
| CA (1) | CA3181427A1 (https=) |
| MX (1) | MX2022014123A (https=) |
| WO (1) | WO2021231988A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115697373A (zh) | 2020-05-15 | 2023-02-03 | 南加利福尼亚大学 | 线粒体衍生肽和其类似物作为包括癌症的年龄相关性疾病的治疗的用途 |
| WO2026021591A1 (zh) * | 2024-07-26 | 2026-01-29 | 南京安吉生物科技有限公司 | 一种新型调节能量代谢的微肽mp29及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9419553D0 (en) * | 1994-09-27 | 1994-11-16 | Univ Bristol | Polypeptides and their use in the treatment of auto-immune disease |
| JP2004520803A (ja) | 2000-04-21 | 2004-07-15 | コリクサ コーポレイション | 尋常性挫瘡の治療および診断のための組成物および方法 |
| CN101586112B (zh) * | 2009-06-19 | 2011-06-22 | 中国科学院上海有机化学研究所 | 诺丝七肽的生物合成基因簇 |
| US20140296139A1 (en) * | 2013-03-15 | 2014-10-02 | The Regents Of The University Of California | Mitochondrial-derived peptide mots3 regulates metabolism and cell survival |
| EP3022222A4 (en) * | 2013-07-18 | 2017-06-07 | Eutropics Pharmaceuticals, Inc. | Differential bh3 mitochondrial profiling |
| BR112016027911A2 (pt) * | 2014-05-28 | 2017-10-24 | Evogene Ltd | polinucleotídeos isolados, polipeptídeos e métodos de uso dos mesmos para aumento da tolerância ao estresse abiótico, biomassa e produção da planta |
| CA3026458A1 (en) * | 2016-06-24 | 2017-12-28 | University Of Southern California | Mentsh analogs as therapeutics for diabetes, obesity, and their associated diseases and complications |
| US11208443B2 (en) * | 2017-02-14 | 2021-12-28 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | NAF-1 derived peptides and uses thereof |
| CN115697373A (zh) | 2020-05-15 | 2023-02-03 | 南加利福尼亚大学 | 线粒体衍生肽和其类似物作为包括癌症的年龄相关性疾病的治疗的用途 |
-
2021
- 2021-05-14 CN CN202180035238.6A patent/CN115697373A/zh active Pending
- 2021-05-14 JP JP2022569147A patent/JP2023528220A/ja active Pending
- 2021-05-14 KR KR1020227043805A patent/KR20230019112A/ko active Pending
- 2021-05-14 US US17/921,577 patent/US12577281B2/en active Active
- 2021-05-14 EP EP21802909.8A patent/EP4149511B1/en active Active
- 2021-05-14 WO PCT/US2021/032641 patent/WO2021231988A2/en not_active Ceased
- 2021-05-14 MX MX2022014123A patent/MX2022014123A/es unknown
- 2021-05-14 CA CA3181427A patent/CA3181427A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5484734B2 (ja) | Ｈｌａ−ａ＊１１０１拘束性ｗｔ１ペプチド、およびそれを含む医薬組成物 | |
| JP2006513724A5 (https=) | ||
| KR20220164079A (ko) | 이미다졸디펩티드를 포함하는 제제 | |
| JP2023528220A5 (https=) | ||
| JP2015520129A (ja) | 多価乳がんワクチン | |
| KR20130055553A (ko) | 환자가 면역치료제에 대한 반응자일지의 여부를 확인하는 방법 | |
| RU2535971C2 (ru) | Тимус-специфический белок | |
| CN116970058B (zh) | 针对tp53基因r249s突变的肿瘤新抗原多肽及其应用 | |
| EP4149511B1 (en) | Mitochondrial-derived peptides and analogs thereof for use as a therapy for age-related diseases including cancer | |
| CN110194800A (zh) | 一种融合蛋白、细胞外泌体和肿瘤疫苗及其应用 | |
| Khavinson et al. | Peptide regulation of aging: 35-year research experience | |
| CN1244584A (zh) | 具有免疫细胞趋化和造血刺激活性的趋化因子 | |
| CN107001434A (zh) | 新型粉尘螨蛋白质 | |
| CN111647069B (zh) | 一种改进的tcr及其应用 | |
| JP4393381B2 (ja) | インターフェロンの効果予測方法 | |
| US20030194764A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| JP2005508157A5 (https=) | ||
| WO2026085068A1 (en) | Heteroclitic neoepitope vaccines | |
| HK40085747A (en) | Mitochondrial-derived peptides and analogs thereof for use as a therapy for age-related diseases including cancer | |
| CN116948004A (zh) | 针对ctnnb1基因h36p突变的肿瘤新抗原多肽及其应用 | |
| CN119241682A (zh) | 一种肝癌相关抗原afp的淋巴细胞抗原表位肽及其应用 | |
| CN121443628A (zh) | 异质新表位疫苗 | |
| JP2004099509A (ja) | ＣＤ８＋細胞傷害性Ｔリンパ球ｍＨＡエピトープペプチド及びその用途 | |
| JP2004147534A (ja) | 免疫調節作用関連の新規遺伝子及びＴｈ１ヘルパーＴ細胞とＴｈ２ヘルパーＴ細胞のバランスを調べる検査方法 | |
| NS2736915 | Prote lne s et peptides |